Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Björn, Wettermark"'
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Objectives Antihypertensives reduce the risk of myocardial infarction and stroke. Restrictions during the COVID-19 pandemic limited access to healthcare, which may have had a negative impact on drug prescribing. This study aimed to assess the effect
Externí odkaz:
https://doaj.org/article/6344232797f842e9a4623dd79521e34b
Trends in statin utilization and ischemic heart disease mortality in Lithuania and Sweden, 2000–2020
Publikováno v:
Upsala Journal of Medical Sciences, Vol 129, Pp 1-8 (2024)
Aims: To compare statin utilization and ischemic heart disease (IHD) mortality trends in Lithuania and Sweden and to assess correlations between the total utilization of statins and IHD mortality. Methods: An ecological study assessing time trends in
Externí odkaz:
https://doaj.org/article/3978bc372e344d40854b33341850f7f5
Autor:
Elkanah Linder, Björn Wettermark, Marie-Louise Ovesjö, Sofia Kälvemark Sporrong, Helena Ramström
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Two publicly available Swedish knowledge support systems, “Pharmaceuticals and Environment” on Janusinfo.se and Fass.se, provide environmental information on pharmaceuticals. Janusinfo is provided by the public healthcare syst
Externí odkaz:
https://doaj.org/article/468990514af84ca8b5cc0a6e4e14ccde
Autor:
Saeed Shakibfar, Jing Zhao, Huiqi Li, Hedvig Nordeng, Angela Lupattelli, Milena Pavlovic, Geir Kjetil Sandve, Fredrik Nyberg, Björn Wettermark, Mohammadhossein Hajiebrahimi, Morten Andersen, Maurizio Sessa
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
AimsTo develop a disease risk score for COVID-19-related hospitalization and mortality in Sweden and externally validate it in Norway.MethodWe employed linked data from the national health registries of Sweden and Norway to conduct our study. We focu
Externí odkaz:
https://doaj.org/article/f8367d792e2b4ff2ac7f3ca03a0c10ec
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 11, Iss , Pp 100303- (2023)
Background: Pharmaceuticals treat and prevent diseases but can pose a risk to organisms, predominantly in aquatic environments. The use of pharmaceuticals is predicted to increase due to, among other factors, a growing and aging population and climat
Externí odkaz:
https://doaj.org/article/25c6d5b629a3439dae33e4a3492a08e3
Autor:
Johanna Villén, Marmar Nekoro, Sofia Kälvemark Sporrong, Helle Håkonsen, Michael G. Bertram, Björn Wettermark
Publikováno v:
Environmental Advances, Vol 12, Iss , Pp 100384- (2023)
Use of pharmaceuticals is continuously increasing globally and their residues are recognized as a risk for the environment. The aim of this study was to investigate drug utilization patterns of analgesics in relation to environmental hazard in the re
Externí odkaz:
https://doaj.org/article/419f79ae91bb44fa86f27750a0f60da3
Autor:
Ailiana Santosa, Stefan Franzén, Jonatan Nåtman, Björn Wettermark, Ingela Parmryd, Fredrik Nyberg
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The impact of statins on COVID-19 remains unclear. This study aims to investigate whether statin exposure assessed both in the population and in well-defined cohorts of COVID-19 patients may affect the risk and severity of COVID-19 using nat
Externí odkaz:
https://doaj.org/article/91f495946a174d1d97358a50a540837c
Autor:
Nataliia Khanyk, Bohdan Hromovyk, Oksana Levytska, Tamas Agh, Björn Wettermark, Przemyslaw Kardas
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Due to the Russian invasion, which started on 24 February 2022, the Ukrainian healthcare system is facing multiple challenges. A great number of healthcare facilities have been destroyed, while availability of other ones is often limited due to a lac
Externí odkaz:
https://doaj.org/article/ecb694b1774f429683ec159846664501
Autor:
Henrike Häbel, PhD, Björn Wettermark, PhD, David Hägg, PhD, Reginald Villacorta, PhD, E.Christina M. Wennerström, PhD, Marie Linder, PhD
Publikováno v:
JAAD International, Vol 3, Iss , Pp 63-75 (2021)
Background: Psoriasis is an immune-mediated chronic inflammatory disease having a significant negative health impact. Psoriasis has societal impact; loss of productivity has been estimated at approximately 10% and it may influence the patient's finan
Externí odkaz:
https://doaj.org/article/cce99b4e1bcd452ca811af446f3cc816
Autor:
Alice Pisana, Björn Wettermark, Amanj Kurdi, Biljana Tubic, Caridad Pontes, Corinne Zara, Eric Van Ganse, Guenka Petrova, Ileana Mardare, Jurij Fürst, Marta Roig-Izquierdo, Oyvind Melien, Patricia Vella Bonanno, Rita Banzi, Vanda Marković-Peković, Zornitsa Mitkova, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Rising expenditure for new cancer medicines is accelerating concerns that their costs will become unsustainable for universal healthcare access. Moreover, early market access of new oncology medicines lacking appropriate clinical evaluati
Externí odkaz:
https://doaj.org/article/a7cb1f6351164908896e1d25ae912be5